维普中文期刊产品整合服务
192篇 您的检索式:作者名="Waeber"
    题名 作者 年代 出处 被引量
1Portopulmonary hypertension and hepatopulmonary syndrome显示文摘Portopulmonary hypertension(POPH) and hepatopulmonary syndrome(HPS) are two frequent complications of liver disease, with prevalence among liver transplant candidates of 6% and 10%, respectively. Both conditions result from a lack of hepatic clearance of vasoactive substances produced in the splanchnic territory. Subsequently, these substances cause mainly pulmonary vascular remodeling and some degree of vasoconstriction in POPH with resulting elevated pulmonary pressure and right ventricular dysfunction. In HPS the vasoactive mediators cause intrapulmonary shunts with hypoxemia. Medical treatment is disappointing overall. Whereas liver transplantation(LT) results in the disappearance of HPS within six to twelve months, its effect on POPH is highly unpredictable. Modern strategies in managing HPS and POPH rely on a thorough screening and grading of the disease's severity, in order to tailor the appropriate therapy and select only the patients who will benefit from LT. The anesthesiologist plays a central role in managing these high-risk patients. Indeed, the important hemodynamic and respiratory modifications of the perioperative period mustbe avoided through continuation of the preoperatively initiated drugs, appropriate intraoperative monitoring and proper hemodynamic and respiratory therapies.Florence Aldenkortt Marc Aldenkortt Laurence Caviezel Jean Luc Waeber Anne Weber Eduardo Schiffer 2014World Journal of Gastroenterology2014,20,25:7
2Hypertension increases eonnexin43 in a tissue-specific manner显示文摘Haefliger JA Castillo E Waeber G 1997Circulation1997,95,4:1
3Migraine as an inflammatory disorder显示文摘Waeber C Moskowitz MA 2005Neurology2005,64,102:1
4Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach显示文摘Jean-Jacques Mourad Bernard Waeber Fa?ez Zannad Maurice Laville Gérard Duru Michel Andréjak 2004Journal of Hypertension2004,,12:1
5Blood pressure measuring devices : Recommendations of the European Society of Hyperten- sion显示文摘OBrien E Waeber B Parati G 2001BMJ2001,322,7285:1
6ADVANCE: a morbidity mortality st- udy of diabetes and hypertension 显示文摘Heim A Feihl F Waeber B 2008Rev Med Suisse2008,4,139:1
7Fatty acids decrease IDX -1 expression in rat pancreatic islets and reduce GLUT2,glucokinase,insulin and somatostatin levels显示文摘Gremlich S Bonny C Waeber G 1997J Biol Chem1997,272,30:1
8Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDDM显示文摘Thorens B Waeber G 1993Diabetes1993,42,9:1
9Echocardiographic analysis in cardiac amyloidosis显示文摘Hurrel C Deriaz Chessex S Waeber G 2006Schweiz Rundsch Med Pra2006,95,24:1
10Advance:a morbidity mortality study of diabetes and hypertension显示文摘Heim A Feihl F Waeber B 2008Rev Med Suisse2008,4,139:1
11Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase显示文摘Endres m Wang ZQ Namura S Waeber C 1997J Cereb Blood Flow Metab1997,17,11:1
12Influence of age,risk factors and cardiovascular and renal disease on arterial stiffness:clinical applications显示文摘Benetos A Waeber B Izzo J 2002Am J Hypertens2002,15,12:1
13Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applica- tions 显示文摘Benetos A Waeber B Izzo J 2002Am J Hypertens2002,15,12:1
14Cytokines and hs-CRP levels in individuals treated with low-doseaspirin for cardiovascular prevention : a population-based study(CoLaus Study) 显示文摘VAUCHER J MARQUES-VIDAL P WAEBER G’ 2014Cytokine2014,66,2:1
15Blood pressure measuring devices:recommendations of the European Society of Hypertension显示文摘O' Brien g waeber B parati G etal 2001BMJ2001,322,7285:1
16Target organ damage : how to detect it and how to treat it? 显示文摘Waeber B de la Sierra A Ruilope LM 2009J Hypertens Suppl2009,27,3:1
17Cholesterol is the major component of native lipoproteins activating the p38 mitogen-activated protein kinases显示文摘Dobreva I Zschornig O Waeber G 2005Biol Chem2005,386,9:1
18Randomized controlled trial ofperipherally inserted central catheters vs peripheral catheters formiddle durationin - hospital intravenous therapy 显示文摘Periard D Monney P Waeber G 2008Journal ofThrombosis and Haemostasis2008,6,8:1
19Influence of age, risk factors, cardiovascular and renal disease on arterial stiffness : clinical applications 显示文摘Benetos A Waeber B Izzo J 2002Am J Hypertens2002,15,12:1
20Fatty acids decreases PDX- 1 expresion in rat pancreatic islets and reduce GLUT2, glucokinase,insulin and somatostatin levels 显示文摘Gremlich S Bonny C Waeber G 1997J Biol Chem1997,272,30:1
返回顶部 每页显示:
共10页 首页 上一页 第1页 下一页 末页 /10 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费